FTC Pushes Congress To Pass Drug Settlement Bill
A top Federal Trade Commission official on Wednesday urged lawmakers to pass legislation banning so-called reverse payment patent settlements between brand-name pharmaceutical companies and their generic competitors....To view the full article, register now.
Already a subscriber? Click here to view full article